Archive for the ‘ New Drugs ’ Category
AAC recommends FDA to approve HGSI, GSK Benlysta
AAC (Arthritis Advisory Committee) recommends US FDA (Food and Drug Administration) to approve HGSI, GSK Benlysta . The Arthritis Advisory Committee of the US Food and Drug Administration (FDA) has voted 13 to 2 to recommend that the FDA approve Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) Benlysta (belimumab) for the treatment of autoantibody-positive patients [...]
